1.Yu，J.，et al.，Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut，2016. 66（1）：p. 70-78.

2.Li，W.，et al.，5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. 2017. 27（10）：p. 1243-1257.

3.Jia，H.，et al.，Water Exchange Method Significantly Improves Adenoma Detection Rate：A Multicenter，Randomized Controlled Trial. Am J Gastroenterol，2017. 112（4）：p. 568-576.

4.Min，M.，et al.，Comparison of linked color imaging and white-light colonoscopy for detection of colorectal polyps：a multicenter，randomized，crossover trial. Gastrointest Endosc，2017. 86（4）：p. 724-730.

5.Liu，Z.，et al.，Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Clinical Cancer Research，2017. 23（23）：p. 7253-7262.

6.Li，N.，et al.，Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer. Gastrointestinal Endoscopy，2017. 85（3）：p. 669-674.

7.Xiong，Y.，et al.，Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma：A definitive anal sphincter-preserving radiotherapy. Scientific Reports，2017. 7：p. 40619.

8.Zhu，X.，et al.，Two-week Course of Preoperative Radiotherapy for Locally Advanced Rectal Adenocarcinoma.American Journal of Clinical Oncology，2017. 40（3）：p. 266-273.

9.Zhang，Y.，et al.，Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer：A comparative analysis after propensity score matching. European Journal of Surgical Oncology（EJSO），2017. 43（8）：p. 1440-1446.

10.Qin，Q.，et al.，Bowel Dysfunction After Low Anterior Resection With Neoadjuvant Chemoradiotherapy or Chemotherapy Alone for Rectal Cancer. Diseases of the Colon & Rectum，2017. 60（7）：p. 697-705.

11.Sun，D.，et al.，Comparison of multi-modal early oral nutrition for the tolerance of oral nutrition with conventional care after major abdominal surgery：a prospective，randomized，single-blind trial. Nutrition Journal，2017. 16（1）.

12.Feng，B.，et al.，Laparoscopic abdominoperineal excision with trans-abdominal individualized levator transection：interim analysis of a randomized controlled trial. Colorectal Disease，2017. 19（7）：p. O246-O252.

13.Xu，J.，et al.，Results of a Randomized，Double-Blind，Placebo-Controlled，Phase Ⅲ Trial of Trifluridine/Tipiracil（TAS-102）Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer：The TERRA Study. J Clin Oncol，2018. 36（4）：p. 350-358.

14.Zhang，C.，et al.，Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers. Molecular Therapy，2017. 25（5）：p. 1248-1258.

15.Xu，R.H.，et al.，Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer：a phase Ib study and a randomized double-blind phase Ⅱ study. J Hematol Oncol，2017. 10（1）：p. 22.

16.Cao，J.，et al.，Phase I Dose‐Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors.The Oncologist，2017. 22（6）：p. 638-e56.

17.Xu，J.，et al.，PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research，2017. 23（16）：p. 4602-4616.

18.Ma，B.，et al.，Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer—a prospective evaluation of circulating tumor cells，18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria. Annals of Oncology，2017. 28（7）：p. 1576-1581.

19.Weng，W.，et al.，Circular RNA ciRS-7—A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer. Clinical Cancer Research，2017. 23（14）：p. 3918-3928.

20.Wang，H.，et al.，PD-L2 expression in colorectal cancer：Independent prognostic effect and targetability by deglycosylation. Oncoimmunology，2017. 6（7）：p. e1327494.

21.Huang，J.，et al.，Elevated tumor-to-liver uptake ratio（TLR）from 18F-FDG-PET/CT predicts poor prognosis in stage ⅡA colorectal cancer following curative resection. European Journal of Nuclear Medicine and Molecular Imaging，2017. 44（12）：p. 1958-1968.

22.Yu，T.，et al.，Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell，2017. 170（3）：p. 548-563.e16.

23.Wong，S.H.，et al.，Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Gastroenterology，2017. 153（6）：p. 1621-1633.e6.

24.Lu，Y.，et al.，lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling. Nature Medicine，2017.

25.Zhao，P.，et al.，Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy. Advanced Functional Materials，2017. 27（44）：p.1700403.